Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective - Top-Institutions - MDSpire

Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective

  • By

  • M Tomblyn

  • T Chiller

  • H Einsele

  • R Gress

  • K Sepkowitz

  • J Storek

  • J R Wingard

  • J-A H Young

  • M J Boeckh

  • October 28, 2009

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematopoietic Cell Transplantation
    • Infectious Diseases
    • Immunology

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematology/Oncology
    • Hematopoietic Cell Transplantation
    • Infectious Diseases

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology/Oncology
    • Hematopoietic Cell Transplantation
    • Infectious Diseases

  • #4

    University of Washington Medical Center
    University of Washington Medical Center

    Seattle, WA

    Key Differentiators

    • Hematopoietic Cell Transplantation
    • Infectious Diseases
    • Immunology

  • #5

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematopoietic Cell Transplantation
    • Infectious Diseases
    • Oncology

Original Source(s)

Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective

  • by M Tomblyn, T Chiller, H Einsele, R Gress, K Sepkowitz, J Storek, J R Wingard, J-A H Young, M J Boeckh

  • October 28, 2009

Related Content

Erratum: Regionally limited or rare infections: prevention after hematopoietic cell transplantation

Blood and marrow transplantation during the emerging COVID-19 pandemic: the Seattle approach

Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis